NEW PD5 DATES: 18 to 20 February 2021
Project Discovery Classic #5: Riding to achieve Neil Sachse’s Vision
The Neil Sachse Centre (NSC) is pleased to confirm that registrations for Project Discovery Classic #5 are still open. Get ready to stretch those legs, meet some AMAZING people, tour the Barossa, taste great wines and raise vital funds for the Project Discovery 5 three-day event.
The PD5 ride will be undertaken in honour of Neil Sachse and his tireless work for Spinal Cord Injury (SCI) research. Neil’s vision remains the focal point of the Neil Sachse Centre: to find a cure for Spinal Cord Injuries and change the future for people living with these disabling conditions.
Project Discovery Classic #5 will take riders on a fun and challenging ride from Adelaide to the Barossa and back. Led by the team at Mondo Cycling Tours, this is the fifth annual ride and the Neil Sachse Centre’s largest annual public fundraiser. More information on Project Discovery Classic 5
Register online (mycause.com.au/events/pd5) today and join us for this three day event. Registration includes the hosted ride, meals and accommodation as well as unique Barossa experiences. This year the Centre has created a registration for partners to come along and support the riders along their journey, and joining them at the end of the day for the evening entertainment and celebrations.
What is Project Discovery? In 2016, the Neil Sachse Centre and SAHMRI launched ‘Project Discovery’, providing the most advanced imaging of the spine with the aim of revolutionising the diagnosis and prognosis of spinal cord injury and other spinal pathologies. The ride was named the ‘Project Discovery Classic’ to raise funds to support this world first research being undertaken by the Centre.
Project Discovery uses positron emission tomography (PET) to image the spinal cord. PET is an imaging technique that produces three-dimensional images by detecting gamma rays emitted by radiopharmaceuticals. The new cyclotron at SAHMRI gives local researchers the ability to source a range of radiopharmaceuticals previously not available. The NSC has progressed on this to the advanced stage of a Clinical Trial scanning people with a SCI; and funds raised by PD5 riders will support this vital work.